VASCUMED
Timeline
39 events since 1982Board
Capital
Filings
Financial
End
198519901995200020052010201520202025
2009
Annual accounts 2009 filed PDFfull format · 34 days late
Merger proposal: to be absorbed by DocpharmaBoard meeting of 08-04-20092 points ▸
- Board meeting of 08-04-2009
- Merger by absorption
1 statutory auditor reappointed and act as permanent representatives · (statutory auditor) · General meeting of 12-03-20095 points ▸
- Board meeting of 10-03-2009
- acts as permanent representative
- acts as permanent representative
- General meeting of 12-03-2009
- reappointed as statutory auditor
- The deed holds 1 more point.
Liquidity more than 9 times current ratio 562.89 The current ratio rises from 58.57 to 562.89. Short-term debt falls from €49,625 to €5,421.
2 directors appointed, 3 resignationsDocpharma NV, and resign · Docpharma NV and appointed · and act as permanent representatives · Board meeting of 14-12-200710 points ▸
- Board meeting of 14-12-2007
- Power of attorney granted to
- General meeting of 14-12-2007
- Docpharma NV resigns as director
- resigns as director
- resigns as director
- Docpharma NV appointed as director
- appointed as director
- acts as permanent representative
- acts as permanent representative
- The deed holds 1 more point.
Annual accounts 2008 filed PDFfull format · 137 days late
2008
Annual accounts 2007 filed PDFfull format · 152 days late
2006
Annual accounts 2006 filed PDFfull format · 29 days late
Weakest financial year net €1,341 The net result drops to €1,341, the lowest from 1998 to 2009.
Liquidity more than 13 times current ratio 37.27 The current ratio rises from 2.68 to 37.27. Short-term debt falls from €1.3m to €70.
Annual accounts 2005 filed PDFabbreviated format · 27 days before the deadline
2005
Highest result from 1998 to 2009 net €575,211 ▲5,093% The net result of €575,211 is the highest of those years.
Liquidity more than doubled current ratio 2.68 The current ratio rises from 1.17 to 2.68. Short-term debt falls from €3.6m to €1.3m.
Equity above €1m equity €1.2m ▲97.2% With a profit in every financial year since 1998, equity grows to €1.2m.
2004
Annual accounts 2004 filed PDFabbreviated format · 39 days before the deadline
2003
Annual accounts 2003 filed PDFabbreviated format · 45 days before the deadline
Equity above €500,000 equity €580,992 ▲43.2% With a profit in every financial year since 1998, equity grows to €580,992.
2002
Annual accounts 2001 filed PDFabbreviated format · 30 days before the deadline
2001
Annual accounts 2000 filed PDFabbreviated format · 33 days before the deadline
2000
Annual accounts 1999 filed PDFabbreviated format · 14 days before the deadline
1999
Annual accounts 1998 filed PDFabbreviated format
1998
Annual accounts 1997 filed NBBabbreviated format
1997
Annual accounts 1996 filed NBBabbreviated format
1996
Annual accounts 1995 filed NBBabbreviated format
1995
Annual accounts 1994 filed NBBabbreviated format
1994
Annual accounts 1993 filed NBBabbreviated format
1993
Annual accounts 1992 filed NBBabbreviated format
1992
Annual accounts 1991 filed NBBabbreviated format
1991
Annual accounts 1990 filed NBBabbreviated format
1990
Annual accounts 1989 filed NBBabbreviated format
1989
Annual accounts 1988 filed NBBabbreviated format
1988
Annual accounts 1987 filed NBBabbreviated format
1987
Annual accounts 1986 filed NBBabbreviated format
1986
Annual accounts 1985 filed NBBabbreviated format
1985
Annual accounts 1984 filed NBBfull format
1984
Annual accounts 1983 filed NBBunclassified schema
1983
Annual accounts 1982 filed NBBunclassified schema
1982
Annual accounts 1981 filed NBBunclassified schema
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank